CN101979092A - Water-soluble veterinary pharmaceutic adjuvant optimal sugar and preparation process thereof - Google Patents

Water-soluble veterinary pharmaceutic adjuvant optimal sugar and preparation process thereof Download PDF

Info

Publication number
CN101979092A
CN101979092A CN2010105328419A CN201010532841A CN101979092A CN 101979092 A CN101979092 A CN 101979092A CN 2010105328419 A CN2010105328419 A CN 2010105328419A CN 201010532841 A CN201010532841 A CN 201010532841A CN 101979092 A CN101979092 A CN 101979092A
Authority
CN
China
Prior art keywords
water
pharmaceutic adjuvant
veterinary
dextrin
soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010105328419A
Other languages
Chinese (zh)
Inventor
曹映海
张笑意
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JIANGSU NANNONG HI-TECH ANIMAL MEDICINE Co Ltd
Nanjing Nannong Hi-Tech Veterinary Drugs Research Institute Co Ltd
Original Assignee
JIANGSU NANNONG HI-TECH ANIMAL MEDICINE Co Ltd
Nanjing Nannong Hi-Tech Veterinary Drugs Research Institute Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JIANGSU NANNONG HI-TECH ANIMAL MEDICINE Co Ltd, Nanjing Nannong Hi-Tech Veterinary Drugs Research Institute Co Ltd filed Critical JIANGSU NANNONG HI-TECH ANIMAL MEDICINE Co Ltd
Priority to CN2010105328419A priority Critical patent/CN101979092A/en
Publication of CN101979092A publication Critical patent/CN101979092A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention provides water-soluble veterinary pharmaceutic adjuvant optimal sugar and a preparation process thereof, which belong to the field of the production of raw materials of veterinary medicaments. The preparation process comprises the following steps of: dissolving magnesium sulfate dodecahydrate, sodium sulphate dihydrate, dextran, dextrine and an appropriate amount of citric acid at high temperature and then cooling to agglomerate; and performing the steps of hydrolyzing and stirring, drying at the temperature of 200 DEG C and the like to obtain crystalline powder. The product has stable properties and pH value and low activity, is difficult to react with medicaments, is nonhygroscopic, is not agglomerate, does not discolor, has high dispersibility and fluidity, and is soluble in water; and the aqueous solution has high clarity; and the water-soluble veterinary pharmaceutic adjuvant optimal sugar has high adsorbability and affinity, has sustained-release and synergy effect and is a stable and efficient veterinary pharmaceutic adjuvant.

Description

Excellent sugar of a kind of water solublity pharmaceutic adjuvant for animals and preparation technology thereof
Technical field:
The present invention relates to a kind of excellent sugar of new type water-solubility veterinary drug pharmaceutic adjuvant and preparation technology thereof, belong to veterinary drug raw material production field.
Background technology:
Fast development along with China's aquaculture, the application of veterinary drug and feed additive is increasingly extensive, now become a ring important in the modern farming, in the veterinary drug of becoming increasingly prosperous is produced, the veterinary drug adjuvant is widely used, but the veterinary drug carrier of present domestic use is mainly glucose, its shortcoming is the easy moisture absorption, easily lump, mobile poor, be difficult for mix homogeneously with medicine, and sweet taste is heavy, and many animals are not liked feed and drink, and makes to enter the intravital medicine of animal and do not reach and require dosage, influence therapeutic effect, so use product one listing of glucose, caking or metachromatism just occur in the very short time, simultaneously some medicine and the easy chemically reactive of glucose as adjuvant, cause and to add, for example neomycin, ammonium chloride etc.
So a kind of stable in properties of urgent need, pH value were stablized during modern veterinary drug was produced; Active low, be difficult for and medicine reacts, nonhygroscopic, do not lump, invariant color; While product dispersibility, good fluidity, soluble in water, aqueous solution clarity height has stronger adsorptivity and affinity, has the pharmaceutic adjuvant of sustained-release synergistic effect.
Excellent sugar is the complex of being made through high-temperature process by plurality of inorganic salt, glucosan, dextrin and citric acid etc.It has stable in properties, good water solubility, mobile good, color and luster evenly, be difficult for moisture absorption and characteristics such as do not lump.With this product is the powder pre-mixing agent of substrate, nonhygroscopic, do not lump, invariant color, help medicine and absorb in animal body and distribute, to improving bioavailability of medicament and increasing curative effect bigger help is arranged.
Summary of the invention:
Technical problem
The invention provides a kind of veterinary drug water solublity pharmaceutic adjuvant, it has stable in properties, PH is stabilized between the 6.5-7, good water solubility, mobile good, color and luster evenly, be difficult for moisture absorption and characteristics such as do not lump.
Technical scheme
A kind of veterinary drug water solublity pharmaceutic adjuvant is characterized in that: described veterinary drug water soluble adjuvant is made up of following raw material:
● excellent sugar (white)
1) 12 water magnesium sulfates: 40%
2) 2 aqueous sodium persulfates: 35%
3) glucosan: 15%
4) dextrin: 10%
● excellent sugar (yellow)
1) 12 water magnesium sulfates: 40%
2) 2 aqueous sodium persulfates: 35%
3) glucosan: 15%
4) dextrin: 6%
5) citric acid: 4%
Simultaneously, the veterinary drug water soluble adjuvant among the present invention is characterized in that: described veterinary drug water soluble adjuvant adopts following prepared:
● excellent sugar (white)
1) earlier with 12 water magnesium sulfates, 2 aqueous sodium persulfates, glucosan, dextrin mixing and stirring;
2) pour high temperature furnace internal heating to 800 degree into and make material dissolution, the postcooling caking.
3) cooled complex stirs through hydrolysis, and dries and produce crystallization with 200 degree
The property powder;
4) 100 mesh sieve branches, the packing warehouse-in.
● excellent sugar (yellow)
1) earlier with 12 water magnesium sulfates, 2 aqueous sodium persulfates, glucosan, dextrin, citric acid mixing and stirring;
2) pour high temperature furnace internal heating to 800 degree into and make material dissolution, the postcooling caking.
3) cooled complex stirs through hydrolysis, and dries and produce crystallization with 200 degree
The property powder;
4) 100 mesh sieve branches, the packing warehouse-in.
Beneficial effect
Product of the present invention by plurality of inorganic salt, glucosan, dextrin and citric acid etc. through high temperature
The complex of handling and making.It has stable in properties, PH is stabilized between the 6.5-7, good water solubility, mobile good, color and luster evenly, be difficult for moisture absorption and characteristics such as do not lump.With this product is the powder pre-mixing agent of substrate, nonhygroscopic, do not lump, invariant color, help medicine and absorb in animal body and distribute, to improving bioavailability of medicament and increasing curative effect bigger help is arranged.
The specific embodiment:
For further setting forth water solublity of the present invention pharmaceutic adjuvant for animals, the spy more elaborates in conjunction with the embodiments.
The invention provides a kind of veterinary drug water solublity pharmaceutic adjuvant, it is characterized in that: described veterinary drug water soluble adjuvant is made up of following raw material:
● excellent sugar (white)
1) 12 water magnesium sulfates: 40%
2) 2 aqueous sodium persulfates: 35%
3) glucosan: 15%
4) dextrin: 10%
● excellent sugar (yellow)
1) 12 water magnesium sulfates: 40%
2) 2 aqueous sodium persulfates: 35%
3) glucosan: 15%
4) dextrin: 6%
5) citric acid: 4%
Wherein, 12 water magnesium sulfates, 2 aqueous sodium persulfates and glucosan are primary raw material, dextrin
Be bulking agent, citric acid is a toner.
Described veterinary drug water soluble adjuvant adopts following prepared:
● excellent sugar (white)
1) earlier with 12 water magnesium sulfates, 2 aqueous sodium persulfates, glucosan, dextrin mixing and stirring;
2) pour high temperature furnace internal heating to 800 degree into and make material dissolution, the postcooling caking.
3) cooled complex stirs through hydrolysis, and dries and produce crystallization with 200 degree
The property powder;
4) 100 mesh sieve branches.
5) examination and test of products:
Product is through check, moisture≤6%; 80 order percent of pass are 100%; PH value (5% solution, 25% ℃): 6.5-7.0; Clarity experiment: clarification; Product meets the enterprise product quality standard through check, the packing warehouse-in.
● excellent sugar (yellow)
1) earlier with 12 water magnesium sulfates, 2 aqueous sodium persulfates, glucosan, dextrin, citric acid mixing and stirring;
2) pour high temperature furnace internal heating to 800 degree into and make material dissolution, the postcooling caking.
3) cooled complex stirs through hydrolysis, and dries and produce crystallization with 200 degree
The property powder;
4) 100 mesh sieve branches.
5) examination and test of products:
Product is through check, moisture≤6%; 60 order percent of pass are 100%; PH value (5% solution, 25% ℃): 6.5-7.0; Clarity experiment: clarification; Product meets the enterprise product quality standard through check, the packing warehouse-in.
Product is the complex of being made through high-temperature process by plurality of inorganic salt, glucosan, dextrin and citric acid etc.It has stable in properties, PH is stabilized between the 6.5-7.0, good water solubility, mobile good, color and luster evenly, be difficult for moisture absorption and characteristics such as do not lump.With this product is the powder pre-mixing agent of substrate, nonhygroscopic, do not lump, invariant color, and help medicine and absorb in animal body and distribute, to improving bioavailability of medicament and increasing curative effect bigger help is arranged.

Claims (2)

1. the excellent sugar of veterinary drug water solublity pharmaceutic adjuvant is characterized in that, is made up of by mass ratio following raw material:
12 water magnesium sulfates 40%; 2 aqueous sodium persulfates 35%; Dextran 15 %; Dextrin 10% or dextrin 6% and citric acid 4%.
2. the preparation technology of the excellent sugar of the described veterinary drug water soluble adjuvant of claim 1 comprises:
1) earlier with 12 water magnesium sulfates, 2 aqueous sodium persulfates, glucosan, dextrin, citric acid mixing and stirring;
2) pour high temperature furnace internal heating to 800 degree into and make material dissolution, the postcooling caking;
3) cooled complex stirs through hydrolysis, produces crystalline powder with 200 degree oven dry;
4) 100 mesh sieve branches, the packing warehouse-in.
CN2010105328419A 2010-11-05 2010-11-05 Water-soluble veterinary pharmaceutic adjuvant optimal sugar and preparation process thereof Pending CN101979092A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010105328419A CN101979092A (en) 2010-11-05 2010-11-05 Water-soluble veterinary pharmaceutic adjuvant optimal sugar and preparation process thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010105328419A CN101979092A (en) 2010-11-05 2010-11-05 Water-soluble veterinary pharmaceutic adjuvant optimal sugar and preparation process thereof

Publications (1)

Publication Number Publication Date
CN101979092A true CN101979092A (en) 2011-02-23

Family

ID=43599649

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010105328419A Pending CN101979092A (en) 2010-11-05 2010-11-05 Water-soluble veterinary pharmaceutic adjuvant optimal sugar and preparation process thereof

Country Status (1)

Country Link
CN (1) CN101979092A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106509372A (en) * 2016-10-09 2017-03-22 杨松杞 New water-soluble carrier and preparation method thereof
CN111955609A (en) * 2020-08-29 2020-11-20 广州承兴生物科技有限公司 Preparation method of water-soluble auxiliary agent for veterinary drug, aquatic product and feed additive
CN114642738A (en) * 2022-03-23 2022-06-21 湖南兴镁源科技股份有限公司 Low-temperature high-solubility water-soluble carrier for livestock and preparation method thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106509372A (en) * 2016-10-09 2017-03-22 杨松杞 New water-soluble carrier and preparation method thereof
CN111955609A (en) * 2020-08-29 2020-11-20 广州承兴生物科技有限公司 Preparation method of water-soluble auxiliary agent for veterinary drug, aquatic product and feed additive
CN114642738A (en) * 2022-03-23 2022-06-21 湖南兴镁源科技股份有限公司 Low-temperature high-solubility water-soluble carrier for livestock and preparation method thereof

Similar Documents

Publication Publication Date Title
CN101979092A (en) Water-soluble veterinary pharmaceutic adjuvant optimal sugar and preparation process thereof
CN104814931A (en) Olaquindox slow release particle and preparing method and application thereof
CN103239422B (en) Preparation method of smellless coated enrofloxacin preparation
CN102948418B (en) A kind of tea saponin tablet and preparation method thereof
CN113952305A (en) Arbidol hydrochloride granules and preparation method thereof
CN109771372A (en) A kind of dextromethorphan hydrobromide sustained-release suspension and preparation method thereof
WO2014183508A1 (en) Biogas residue-containing formula feed for chicken
CN107375247B (en) Tilmicosin film-controlled enteric sustained-release preparation and preparation method thereof
CN103652366B (en) A kind of stabilization micro-capsule coating Mercaptamine and preparation method thereof
CN103520188B (en) A kind of poultry compound antibacterial dry suspension and preparation method thereof
CN114288259B (en) Quick-release preparation of vitamin B2 and preparation method thereof
CN100558404C (en) Water-solubility carrier
CN110179756A (en) A kind of tilmicosin micro-capsule preparation and preparation method thereof
CN104224725A (en) Tebipenem pivoxil granule and preparation method thereof
CN115645376A (en) Tilmicosin efficient double-layer coated pellet and preparation method thereof
CN112494460B (en) Tilmicosin powder and preparation method thereof
CN102657634B (en) Nifuroxazide microcapsule powder and production method thereof
CN101108251B (en) Preparation of medicinal disintegrating agent with biological enzymatic isolation method
CN1319533C (en) Cefetamet pivoxil hydrochloride dispersion dispersion tablets and preparation method
CN107296800A (en) A kind of Loratadine effervescent tablet and preparation method thereof
CN107019677A (en) The preparation method of amoxicillin dispersible tablet
CN102895202A (en) Cefetamet pivoxil hydrochloride dispersible tablet and preparation method thereof
CN102860984B (en) Method for preparing compound sulfachloropyridazine sodium powder
CN108478588A (en) A kind of Tilmicosin enteric-coated sustained release agent and preparation method thereof
CN108125193A (en) A kind of preparation method of food additive citric acid iron

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20110223